Lexeo Therapeutics, Inc. (LXEO) Tops Q2 EPS by 31c

Lexeo Therapeutics, Inc. (NASDAQ: LXEO) reported Q2 EPS of ($0.60), $0.31 better than the analyst estimate of ($0.91).

For earnings history and earnings-related data on Lexeo Therapeutics, Inc. (LXEO) click here.

You May Also Be Interested In

• DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
• Four Tree Island Advisory calls DoubleDown $11.25 offer too low
• Tesla to launch Cybercab in Austin this month - report